Search results
Exercise at One Time of Day Might Be Best for Blood Sugar Control
US News & World Report· 1 day agoThis was particularly true of people with the sort of impaired blood sugar regulation associated with diabetes, researchers said. The ...
People Are Living Longer With Type 1 Diabetes
Homenewshere.com· 4 hours agoPeople with type 1 diabetes are 25% less likely to die early now than they were in 1990, a new global tally finds, and the number of people who've lived...
What Usher Wants Parents With Kids With Type 1 Diabetes To Know
Parents via Yahoo News· 3 days agoSupport groups, such as through the American Diabetes Association and Breakthrough T1D, can be...
Common low-calorie sweetener linked to heart attack and stroke, study finds
CBS 58 Milwaukee· 7 days agoStanley Hazen, director of the Center for Cardiovascular Diagnostics...Prevention at the Cleveland ClinicLerner Research Institute. “When you eat sugar, your glucose
Tasty Treats You Would Never Guess Are Diabetic-Friendly
Cheapism via AOL· 3 days agoHaving diabetes doesn't mean having to avoid dessert. These recipes yield sweet treats that are...
Research seeks to demystify obesity's link to type 2 diabetes
Medical Xpress· 2 days agoThe study is published in the journal Diabetes. Dr. Hanieh Yaghootkar, Senior Lecturer in Precision...
More young people are having strokes. A doctor shares 3 ways to help prevent them.
INSIDER via Yahoo News· 7 days agoGet your heart rate up every day Samarasekera said that ideally, everyone should aim to do 30...
Social determinants of health linked with youth-onset prediabetes
Medical Xpress· 2 days agoThe findings suggest that screening for social determinants of health—the non-medical factors that...
Artificial Sugar Xylitol and Heart Attack Risk: What to Know
Healthline· 6 days agoA new report, published on June 6, suggests xylitol might impair the body’s clotting abilities....
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
Morningstar· 5 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational ...